Q: Revenue grew 79% and the shares fell 23.7%. What did investors see?

A: The composition. In-force premium, the annualised value of the policies actually on the books, grew 32.5% to $1.43 billion. Management attributed the gap to higher premium retention following reinsurance renewals, meaning Lemonade now keeps more of the premium it writes rather than ceding it to reinsurers. That lifts reported revenue without a single additional policy being sold, and it shifts underwriting risk onto Lemonade’s own balance sheet. The underlying growth rate is 32.5%.

Q: Was anything else disappointing?

A: Adjusted earnings came in at a loss of $0.56 per share, exactly matching the forecast rather than beating it, and full-year guidance was reiterated rather than raised. For a share priced on acceleration, an in-line loss and an unchanged outlook were enough.

Q: What actually improved?

A: Considerably more than the reaction implies. The adjusted EBITDA loss halved to $19 million from $41 million a year earlier. Adjusted free cash flow was positive for a fifth consecutive quarter. The loss adjustment expense ratio, which measures the cost of handling claims, fell to a record 5%, and president Shai Wininger said competitors spend almost twice as much. In-force premium growth accelerated for an eleventh straight quarter, roughly 166,000 customers were added, and car insurance revenue grew 60% as autonomous vehicle cover launched in Colorado and Indiana.

Q: So is it cheap now?

A: Cheaper. At $54.11 the shares sit 12.9% below the pre-release close and roughly a third below the recent high, on about 3.4 times full-year revenue guidance. That is still a software multiple applied to an insurance balance sheet, and the reinsurance change nudges the company toward the insurer end of that spectrum rather than the software end.

Q: What would change the rating?

A: One dated event. Lemonade has guided to positive adjusted EBITDA in the fourth quarter of 2026 and maintained that guidance this quarter. Delivering it would convert the profitability story from a promise into a demonstrated fact and would justify a Buy even above today’s price. Deferring it into 2027 would call the entire operating-leverage thesis into question.

The rating stays Watchlist. This is not indecision so much as recognition that nearly every strand of the argument converges on one dated, binary event. With an average daily move of 8.3% and scenario values spanning $40 to $82, there is no premium for guessing ahead of a test that arrives within three months. The complete Lemonade (LMND) report is on our Reports page.